Ligand Pharmaceuticals Incorporated acquired the Verrow Pharmaceuticals, Inc. from Vernon Rowe for $2 million.

Ligand Pharmaceuticals Incorporated (NasdaqGM:LGND) acquired the assets and related liabilities of Verrow Pharmaceuticals, Inc. from Vernon Rowe for $2 million on January 11, 2018. The consideration also includes certain earn-out payment. Ligand Pharmaceuticals Incorporated (NasdaqGM:LGND) completed the acquisition of the assets and related liabilities of Verrow Pharmaceuticals, Inc. from Vernon Rowe on January 11, 2018.